Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

3.400

+0.080 (2.41%)

At close: Jul 31, 2026, 4:00 PM EDT

3.360

-0.040 (-1.18%)

After-hours: Jul 31, 2026, 7:37 PM EDT

Niagen Bioscience Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	130.42	129.42	99.6	83.57	72.05	67.45
Revenue Growth	20.84%	29.95%	19.18%	15.99%	6.82%	13.83%
Gross Profit	83.83	83.19	61.59	50.78	42.8	41.49
Operating Income	11.1	12.31	7.73	-5.6	-18.63	-27.07
Net Income	18.64	17.38	8.55	-4.94	-16.54	-27.13
Earnings Per Share	0.21	0.20	0.11	-0.07	-0.24	-0.40
EPS Growth	18.45%	81.82%	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Ingredients	29.07	28.68	19.81	11.14	8.74	7.41
Analytical Reference Standards and Services	2.69	3.08	3.01	2.91	3.2	3.34
Consumer Products	98.58	97.67	76.77	69.53	60.11	56.71
Total	130.42	129.42	99.6	83.57	72.05	67.45

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	66.55	64.79	44.66	27.33	20.44	28.22
Total Debt	2.58	2.82	2.65	3.28	4.26	4.7
Net Cash (Debt)	63.97	61.97	42.01	24.05	16.18	23.52
Net Cash Growth	22.81%	47.52%	74.69%	48.59%	-31.18%	56.16%
Net Cash Per Share	0.75	0.73	0.54	0.32	0.23	0.35

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4.43	13.5	12.11	7.12	-15.1	-24.16
Capital Expenditures	-0.32	-0.29	-0.16	-0.15	-0.33	-0.41
Free Cash Flow	4.11	13.21	11.95	6.97	-15.43	-24.57
Free Cash Flow Growth	-78.99%	10.60%	71.42%	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.28%	64.28%	61.84%	60.76%	59.40%	61.51%
Operating Margin	8.51%	9.51%	7.76%	-6.70%	-25.85%	-40.14%
Pretax Margin	13.75%	12.47%	10.02%	-5.91%	-22.96%	-40.22%
Profit Margin	12.93%	11.84%	9.72%	-5.91%	-22.96%	-40.22%
FCF Margin	3.15%	10.21%	11.99%	8.34%	-21.42%	-36.43%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.19	31.80	48.27	-	-	-
Forward PE	19.15	27.81	50.28	160.00	160.00	160.00
P/FCF Ratio	66.09	38.37	34.37	15.39	-	-
PS Ratio	2.08	3.92	4.12	1.28	1.74	3.78